Responses
Emerging technologies, pharmacology and therapeutics
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
Compose a Response to This Article
Other responses
No responses have been published for this article.